New Key Statistics Module, Z-Score and F-Score
SHSE:600812 Key Ratios
Market Cap ¥ M | 8,184.03 |
Enterprise Value ¥ M | 17,890.90 |
P/E(ttm) | 159.00 |
PE Ratio without NRI | 265.00 |
Forward PE Ratio | -- |
Price/Book | 1.53 |
Price/Sales | 0.76 |
Price/Free Cash Flow | 7.97 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 10,117.00 |
EPS (TTM) ¥ | 0.03 |
Beneish M-Score | -2.78 |
10-y EBITDA Growth Rate % | 7.00 |
5-y EBITDA Growth Rate % | -0.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 25.63 |
EV-to-EBITDA | 25.63 |
PEG | -- |
Shares Outstanding M | 1,715.73 |
Net Margin (%) | 0.50 |
Operating Margin % | 6.12 |
Pre-tax Margin (%) | 2.19 |
Quick Ratio | 0.54 |
Current Ratio | 0.77 |
ROA % (ttm) | 0.24 |
ROE % (ttm) | 0.94 |
ROIC % (ttm) | 1.45 |
Dividend Yield % | 0.21 |
Altman Z-Score | 0.72 |
SHSE:600812 Number of Guru Trades
SHSE:600812 Volume of Guru Trades
Gurus Latest Trades with SHSE:600812
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600812 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
North China Pharmaceutical Co Ltd Insider Transactions
No Available Data